An observational study in Shoulder Pain, sponsored by Suleyman Demirel University. Completed at 1 site in Turkey. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2018-06-06.
Sponsored by Suleyman Demirel University · Observational
In this study, it was aimed to determine the relationship between pathologic findings and coracoacromial ligament thickness in magnetic resonance imaging in shoulder pain patients.
The coracoacromial ligament, which is part of the coracoacromial arch, plays an important role in shoulder biomechanics, joint stability and proprioception. Age-related changes due to chronic stress and cellular impairment may contribute to thickening and stiffening of the coracoacromial ligament to rupture the rotator cuff and development of shoulder pathologies such as impingement syndrome. In this study, it was aimed to determine the relationship between pathologic findings and coracoacromial ligament thickness in magnetic resonance imaging in shoulder pain patients. Secondary purpose is whether the thickness of the coracoacromial ligament is indicative of shoulder pathologies.
707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.
This study's enrollment of 253 is above the median of 82 across 130 observational studies indexed under Shoulder Pain.
Browse Shoulder Pain studies →Suleyman Demirel University is the lead sponsor of 123 studies on the registry; 36 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with shoulder pain
Exclusion Criteria:
magnetic resonance imaging of shoulder
Thickness of coracoacromial ligament
magnetic resonance imaging of coracoacromial ligament
Time frame: 1 week
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Suleyman Demirel University